aripiprazole has been researched along with Anxiety Disorders in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (40.00) | 29.6817 |
| 2010's | 11 (55.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benites-Zapata, VA; Campos-Rodriguez, SK; Fernández, MF; Ortiz-Saavedra, B; Pino-Zavaleta, DA; Valdivieso-Jiménez, G | 1 |
| Blumberger, DM; Buchalter, ELF; Dixon, D; Karp, JF; Lenze, EJ; Miller, JP; Mulsant, BH; Oughli, HA; Reynolds, CF | 1 |
| Beach, SR; Celano, CM; Chen, JA; Ptaszek, LM | 1 |
| Citrome, LL; Manning, JS; McIntosh, D; McIntyre, RS | 1 |
| Brawman-Mintzer, O; Gros, DF; Hershenberg, R | 1 |
| Calabrò, G; Caloro, M; Cuomo, I; De Filippis, S; Girardi, P; Kotzalidis, GD; Ranieri, V; Telesforo, CL; Zingaretti, P | 1 |
| Connolly, JG; Schneeweiss, MC; Toomey, TJ | 1 |
| Delong, HR; Hoge, EA; Kaufman, RE; Pollack, MH; Simon, NM; Worthington, JJ | 1 |
| Berman, RM; Carlson, BX; Fava, M; Marcus, RN; Nelson, CJ; Pikalov, A; Qi, Y; Thase, ME; Tran, QV; Trivedi, MH; Yang, H | 1 |
| Baker, RA; Berman, RM; Carlson, BX; Eudicone, JM; Mankoski, R; Nelson, JC; Pikalov, A; Tran, QV | 1 |
| Jackson, CW; Lorenz, RA; Saitz, M | 1 |
| McIntyre, RS | 1 |
| Katzman, MA | 1 |
| Sajatovic, M | 1 |
| Carson, WH; Kitagawa, H | 1 |
| Kinrys, G; Pollack, MH; Worthington, JJ; Wygant, LE | 1 |
| Adson, DE; Fahnhorst, TA; Kushner, MG | 1 |
| Dobkin, RD; Marin, H; Menza, MA | 1 |
| Masand, PS; Pae, CU; Patkar, AA; Serretti, A | 1 |
6 review(s) available for aripiprazole and Anxiety Disorders
| Article | Year |
|---|---|
Efficacy and Safety of Aripiprazole in Borderline Personality Disorder: A Systematic Review.
Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Borderline Personality Disorder; Female; Humans; Male; Olanzapine | 2023 |
Role of atypical antipsychotics in the treatment of generalized anxiety disorder.
Topics: Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Generalization, Psychological; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Treatment Outcome | 2014 |
Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.
Topics: Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Drug Resistance; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2010 |
Aripiprazole: a clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Anxiety Disorders; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Mental Disorders; Piperazines; Quinolones | 2011 |
Treatment for mood and anxiety disorders: quetiapine and aripiprazole.
Topics: Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Dibenzothiazepines; Humans; Mood Disorders; Piperazines; Quetiapine Fumarate; Quinolones | 2003 |
Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence.
Topics: Animals; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Depressive Disorder; Humans; Piperazines; Quinolones | 2008 |
6 trial(s) available for aripiprazole and Anxiety Disorders
| Article | Year |
|---|---|
Predicting Remission in Late-Life Major Depression: A Clinical Algorithm Based Upon Past Treatment History.
Topics: Algorithms; Antidepressive Agents; Anxiety Disorders; Aripiprazole; Clinical Decision Rules; Comorbidity; Delayed-Action Preparations; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Humans; Likelihood Functions; Prospective Studies; Recurrence; Treatment Outcome; Venlafaxine Hydrochloride | 2019 |
Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Body Weight; Comorbidity; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Quinolones; Treatment Outcome | 2008 |
Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post-hoc, pooled analysis of two large, placebo-controlled studies.
Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2010 |
Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients.
Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Depressive Disorder; Drug Resistance; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 2005 |
Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors.
Topics: Adult; Aged; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Comorbidity; Depressive Disorder; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2005 |
An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Bupropion; Dizziness; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Headache; Humans; Male; Middle Aged; Nausea; Paroxetine; Pilot Projects; Piperazines; Quality of Life; Quinolones; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2007 |
8 other study(ies) available for aripiprazole and Anxiety Disorders
| Article | Year |
|---|---|
Case 9-2019: A 62-Year-Old Man with Atrial Fibrillation, Depression, and Worsening Anxiety.
Topics: Adrenergic beta-Antagonists; Alcohol Drinking; Antidepressive Agents; Anxiety Disorders; Aripiprazole; Arrhythmias, Cardiac; Atrial Fibrillation; Depressive Disorder, Major; Diagnosis, Differential; Electrocardiography; Humans; Male; Middle Aged; Pacemaker, Artificial; Sotalol | 2019 |
Activating and Sedating Properties of Medications Used for the Treatment of Major Depressive Disorder and Their Effect on Patient Functioning.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Arousal; Comorbidity; Delayed-Action Preparations; Depressive Disorder, Major; Drug Approval; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Practice Patterns, Physicians'; Quality of Life; Quetiapine Fumarate; Quinolones; Sleep Initiation and Maintenance Disorders; Thiophenes | 2019 |
Hiccup with aripiprazole plus benzodiazepines resolving with pregabalin and/or benzodiazepine switch/discontinuation: four case reports.
Topics: Adolescent; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Calcium Channel Blockers; Hiccup; Humans; Male; Marijuana Abuse; Pregabalin; Psychoses, Substance-Induced; Psychotic Disorders; Substance-Related Disorders; Young Adult | 2015 |
Metabolic monitoring for youths initiating use of second-generation antipsychotics, 2003-2011.
Topics: Adolescent; Affective Disorders, Psychotic; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Blood Glucose; Child; Child, Preschool; Cohort Studies; Conduct Disorder; Databases, Factual; Depressive Disorder; Diabetes Mellitus; Female; Glycated Hemoglobin; Guideline Adherence; Humans; Hyperkinesis; Male; Mass Screening; Mental Disorders; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Thiazoles | 2015 |
Editorial.
Topics: Antidepressive Agents; Anxiety Disorders; Aripiprazole; Cost-Benefit Analysis; Cross-Cultural Comparison; Delayed-Action Preparations; Depressive Disorder; Drug Costs; Humans; Injections, Intramuscular; Insurance Coverage; Insurance, Pharmaceutical Services; Schizophrenia | 2015 |
Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Panic Disorder; Personality Inventory; Piperazines; Prospective Studies; Quinolones; Treatment Outcome | 2008 |
Aripiprazole: striving towards euthymia with a novel mechanism of action.
Topics: Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Humans; Mood Disorders; Piperazines; Quinolones | 2011 |
Drug development for anxiety disorders: new roles for atypical antipsychotics.
Topics: Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Depressive Disorder; Drug Therapy, Combination; Humans | 2004 |